Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case

Recall Insight

This FDA Food action (record #F-1756-2018) was formally reported on August 15, 2018, with the manufacturer initiating the action on July 27, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Seroyal International, a division of Atrium Innovations is listed as the recalling firm, operating out of Richmond Hill, Ontario. Federal records indicate 4,226 bottles (1691 Canada and 2535 USA) units are affected, placing this recall in the million-unit bracket that typically triggers nationwide consumer alerts and retailer sweeps.

The documented reason for this recall is: Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification. Distribution data in the federal record shows the product reached: Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 8 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.